or
forgot password

    • cancer clinical trials in londonderry, NH

    • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Dana-Farber Cancer Institute at Londonderry
    Londonderry, New Hampshire 03053
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Dana-Farber Cancer Institute at Londonderry
    Londonderry, New Hampshire 03053
    Metastatic Cancer, Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    The Dana-Farber Cancer Institute at Londonderry
    Londonderry, New Hampshire 03053
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    The Dana-Farber Cancer Institute at Londonderry
    Londonderry, New Hampshire 03053
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    The Dana-Farber Cancer Institute at Londonderry
    Londonderry, New Hampshire 03053
    Breast Cancer
    T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
    Dana-Farber Cancer Insitute at Londonderry Hospital
    Londonderry, New Hampshire 03053
    Breast Cancer